293 related articles for article (PubMed ID: 28711141)
1. Genomic Influences on Hyperuricemia and Gout.
Merriman T
Rheum Dis Clin North Am; 2017 Aug; 43(3):389-399. PubMed ID: 28711141
[TBL] [Abstract][Full Text] [Related]
2. An update on the genetic architecture of hyperuricemia and gout.
Merriman TR
Arthritis Res Ther; 2015 Apr; 17(1):98. PubMed ID: 25889045
[TBL] [Abstract][Full Text] [Related]
3. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
[TBL] [Abstract][Full Text] [Related]
4. Genetics of gout.
Choi HK; Zhu Y; Mount DB
Curr Opin Rheumatol; 2010 Mar; 22(2):144-51. PubMed ID: 20110790
[TBL] [Abstract][Full Text] [Related]
5. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
Kawamura Y; Nakaoka H; Nakayama A; Okada Y; Yamamoto K; Higashino T; Sakiyama M; Shimizu T; Ooyama H; Ooyama K; Nagase M; Hidaka Y; Shirahama Y; Hosomichi K; Nishida Y; Shimoshikiryo I; Hishida A; Katsuura-Kamano S; Shimizu S; Kawaguchi M; Uemura H; Ibusuki R; Hara M; Naito M; Takao M; Nakajima M; Iwasawa S; Nakashima H; Ohnaka K; Nakamura T; Stiburkova B; Merriman TR; Nakatochi M; Ichihara S; Yokota M; Takada T; Saitoh T; Kamatani Y; Takahashi A; Arisawa K; Takezaki T; Tanaka K; Wakai K; Kubo M; Hosoya T; Ichida K; Inoue I; Shinomiya N; Matsuo H
Ann Rheum Dis; 2019 Oct; 78(10):1430-1437. PubMed ID: 31289104
[TBL] [Abstract][Full Text] [Related]
7. The genetic basis of hyperuricaemia and gout.
Merriman TR; Dalbeth N
Joint Bone Spine; 2011 Jan; 78(1):35-40. PubMed ID: 20472486
[TBL] [Abstract][Full Text] [Related]
8. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.
Matsuo H; Yamamoto K; Nakaoka H; Nakayama A; Sakiyama M; Chiba T; Takahashi A; Nakamura T; Nakashima H; Takada Y; Danjoh I; Shimizu S; Abe J; Kawamura Y; Terashige S; Ogata H; Tatsukawa S; Yin G; Okada R; Morita E; Naito M; Tokumasu A; Onoue H; Iwaya K; Ito T; Takada T; Inoue K; Kato Y; Nakamura Y; Sakurai Y; Suzuki H; Kanai Y; Hosoya T; Hamajima N; Inoue I; Kubo M; Ichida K; Ooyama H; Shimizu T; Shinomiya N
Ann Rheum Dis; 2016 Apr; 75(4):652-9. PubMed ID: 25646370
[TBL] [Abstract][Full Text] [Related]
10. The genetics of hyperuricaemia and gout.
Reginato AM; Mount DB; Yang I; Choi HK
Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
[TBL] [Abstract][Full Text] [Related]
11. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
[TBL] [Abstract][Full Text] [Related]
12. Genetics of hyperuricemia and gout: implications for the present and future.
George RL; Keenan RT
Curr Rheumatol Rep; 2013 Feb; 15(2):309. PubMed ID: 23307580
[TBL] [Abstract][Full Text] [Related]
13. ABCG2/BCRP dysfunction as a major cause of gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
[TBL] [Abstract][Full Text] [Related]
14. Variants of ALPK1 with ABCG2, SLC2A9, and SLC22A12 increased the positive predictive value for gout.
Tu HP; Min-Shan Ko A; Lee SS; Lee CP; Kuo TM; Huang CM; Ko YC
J Hum Genet; 2018 Jan; 63(1):63-70. PubMed ID: 29215084
[TBL] [Abstract][Full Text] [Related]
15. Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.
Jing J; Ekici AB; Sitter T; Eckardt KU; Schaeffner E; Li Y; Kronenberg F; Köttgen A; Schultheiss UT
Sci Rep; 2018 Sep; 8(1):13184. PubMed ID: 30181573
[TBL] [Abstract][Full Text] [Related]
16. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank.
Sandoval-Plata G; Morgan K; Abhishek A
Ann Rheum Dis; 2021 Sep; 80(9):1220-1226. PubMed ID: 33832965
[TBL] [Abstract][Full Text] [Related]
17. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
[TBL] [Abstract][Full Text] [Related]
18. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
19. Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk.
Tu HP; Chung CM; Min-Shan Ko A; Lee SS; Lai HM; Lee CH; Huang CM; Liu CS; Ko YC
J Hum Genet; 2016 Sep; 61(9):803-10. PubMed ID: 27225847
[TBL] [Abstract][Full Text] [Related]
20. Identification of ABCG2 dysfunction as a major factor contributing to gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
